The Global LabOnAChip Market is expanding rapidly as healthcare systems worldwide adopt miniaturized diagnostic technologies to improve speed, reduce costs, and enhance clinical outcomes. Labonachip (LoC) devices integrate multiple laboratory functions — such as biochemical assays, DNA sequencing, and pointofcare diagnostics — onto a single chip, enabling ultrafast and...

The Global Lab-on-a-Chip Market is growing quickly as healthcare providers, research institutions, and pharmaceutical companies adopt miniaturized diagnostic and analytical solutions. Valued at USD 6.78 billion in 2024, the market is expected to reach USD 14.66 billion by 2032, with a CAGR of 10.12% during this period. The increasing demand comes from the need for fast, accurate, and affordable...